HepC Micro-elimination on MSM and TGW Population.
NCT06847958 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13161
Last updated 2025-02-26
Summary
This is an observational study, in which a single visit will be carried out, which includes a questionnaire on sexual habits and in which the possibility of carrying out a screening for Hepatitis C will be offered. Depending on the score obtained in the questionnaire, the screening will be carried out using a rapid serology test or viral load. During the first year, a SCORE will be developed to classify the risk of positive results. This SCORE will be used during phase 2 to offer users of the centres a targeted screening based on the Pre-test score.
Conditions
- Hepatitis C
- PrEP
- Drugs of Abuse
Sponsors & Collaborators
-
Fundació Lluita contra les Infeccions
collaborator UNKNOWN -
Germans Trias i Pujol Hospital
collaborator OTHER -
Projecte dels NOMS Hispanosida
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-23
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- Spain
Study Locations
More Related Trials
-
Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4
NCT02886624 ·Status: COMPLETED ·Phase: PHASE2
-
Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment
NCT01585584 ·Status: COMPLETED ·Phase: PHASE3
-
Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
NCT02057003 ·Status: UNKNOWN
-
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
NCT01463956 ·Status: COMPLETED ·Phase: PHASE2
-
Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina.
NCT06373198 ·Status: NOT_YET_RECRUITING
-
Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins
NCT02574884 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1
NCT01508130 ·Status: COMPLETED
-
HCV Treatment in a Low-threshold Clinic
NCT04063839 ·Status: UNKNOWN
-
Eliminating Hepatitis C Virus
NCT03401697 ·Status: COMPLETED
-
Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics
NCT02759861 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection
NCT03098121 ·Status: COMPLETED ·Phase: PHASE4
-
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
NCT04610762 ·Status: COMPLETED
-
HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin
NCT01718301 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
NCT01121705 ·Status: COMPLETED ·Phase: PHASE3
-
Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
NCT06904820 ·Status: RECRUITING
-
Multidisciplinary Support Program in Chronic Hepatitis C
NCT01850745 ·Status: COMPLETED
-
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
NCT00164060 ·Status: TERMINATED
-
Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
NCT01878799 ·Status: COMPLETED ·Phase: PHASE2
-
Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)
NCT02768961 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis C Screening Alerts
NCT05710120 ·Status: COMPLETED
-
Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients
NCT02897596 ·Status: UNKNOWN ·Phase: PHASE3
-
Therapeutic Option for Hepatitis B and C: a French Cohort
NCT01953458 ·Status: UNKNOWN
-
Early Detection of HCV in Injection Drug Users
NCT06431945 ·Status: RECRUITING
-
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
NCT03341871 ·Status: COMPLETED
-
Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
NCT02591277 ·Status: COMPLETED